Overview

Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa

Status:
Completed

Trial end date:
2010-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study was to assess the comparative safety and effectiveness of aztreonam for inhalation solution versus tobramycin inhalation solution in adult and pediatric patients with cystic fibrosis (CF) and pulmonary Pseudomonas aeruginosa (PA) infection.

Phase:

Phase 3

Details

Lead Sponsor:

Gilead Sciences

Collaborators:

Chiltern International Inc.
ClinPhone, Inc.
Covance

Treatments:

Anti-Bacterial Agents
Antibiotics, Antitubercular
Aztreonam
Pharmaceutical Solutions
Tobramycin